European equities get thin coverage today, but what's out there leans cautiously constructive — more about relative preference and short-term charts than any big directional call.
Researchers argue the Eurozone looks attractive as part of rotating away from crowded AI and tech exposure, though it's framed as a relative preference rather than a hard target. A separate strand of published analysis links European shares to geopolitics, suggesting a US–Iran de-escalation that brings energy prices down would disproportionately help energy-dependent Europe. That camp attributes much of the recent broad rally in European stocks to Middle East developments rather than fundamentals.
On the technical side, some recently published chart work points to AstraZeneca rebounding from its August low near £114 and pushing above its 200-day moving average after well-received results — read as a constructive near-term bias. The DAX, meanwhile, was indicated roughly 0.2% higher at the week's open following Friday's 0.85% drop, a tactical note rather than a longer-term view.